
Increasingly, anemia is being recognized as a negative zzso and zzso factor for patients undergoing chemotherapy, radiation therapy, or a combination of these treatment zzso The results of clinical studies have shown correlations between anemia and shorter survival times in patients with a wide variety of solid tumors and zzso zzso including zzso zzso breast, and zzso zzso zzso lymphoma, Hodgkin's disease, zzso zzso and chronic zzso zzso Also, anemia has been shown to predict treatment response in patients with zzso zzso and zzso zzso mantle cell lymphoma, and chronic zzso zzso as well as zzso acute zzso zzso Based on the presumed zzso relationship between anemia and poor patient outcome, several studies have examined the influence of zzso zzso (a zzso human zzso on outcomes in anemic patients undergoing cancer zzso The results of these studies have been encouraging, with indications of greater zzso tumor control and higher response rates in zzso zzso zzso Additionally, zzso zzso therapy, by correcting zzso has been shown to improve a patient's energy level, ability to perform daily activities, and overall quality of life zzso Such effects not only enhance a patient's general well-being, but may also increase their tolerance of, and willingness to zzso full courses of their cancer therapy in a timely zzso These findings support the use of zzso zzso to achieve gains in zzso and cancer treatment outcomes in anemic cancer patients and suggest that additional studies be conducted to further investigate the potential benefits of this agent in regard to improved zzso 

